First Generic Versions of Coreg™, FDA-Approved
Filed in archive FDA Approvals , Treatment by Gloria Gamat on September 10, 2007
Coreg™ - a product of GlaxoSmithKline - is a widely used FDA-approved medication for the treatment of high blood pressure, mild to severe chronic heart failure and left ventricular dysfunction following a heart attack.
Now, the FDA has recently approved the first generic versions of Coreg™ (carvedilol) from the following drug companies:
I have always been sceptical of it actually, thinking that though it is cheaper, it is less effective than that of the original branded version. But that's just me. What do you think of generic drugs?
Source: FDA News
[Photo Credit: australian-pharmacies.com]
Now, the FDA has recently approved the first generic versions of Coreg™ (carvedilol) from the following drug companies:
- Actavis Elizabeth LLC
- Apotex Inc.
- Aurobindo Pharma Limited
- Caraco Pharmaceutical Laboratories Limited
- Dr. Reddy's Laboratories
- Glenmark Pharmaceuticals Limited
- lupin
Limited - Mylan Pharmaceuticals Inc.
- Ranbaxy Laboratories Ltd.
- Sandoz Inc.
- Taro Pharmaceutical Industries Ltd.
- TEVA Pharmaceuticals USA
- Watson Laboratories Inc.
- and Zydus Pharmaceuticals USA Inc.
I have always been sceptical of it actually, thinking that though it is cheaper, it is less effective than that of the original branded version. But that's just me. What do you think of generic drugs?
Source: FDA News
[Photo Credit: australian-pharmacies.com]
Permalink: First Generic Versions of Coreg™, FDA-Approved
Tags:
Coreg™ carvedilol high blood pressure heart failure contact contact+lenses
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/90895
